BSH 2019 | Defining the group of MCL patients who do well without treatment
Simon Rule
• 1 Apr 2019
Simon Rule, MD, Plymouth University, Plymouth, UK, speaks at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK. He discusses the watch-and-wait strategy in mantle cell lymphoma (MCL), and research being done to help define the group of patients who can do well without treatment.
